Medical Elastomer Market by Type (Thermoset Elastomers; Thermoplastic Elastomers), Applications (Medical Tubing; Catheters; Syringes; Gloves; Medical & Infusion Bags and Implants), End-use Industry & Region - Global Forecast to 2029
The medical elastomer market is projected to reach USD 14.27 billion by 2029 from USD 9.57 billion in 2024, at a CAGR of 8.3%. Growing demand for medical devices is fueling the demand for medical elastomers worldwide. This is a result of the increased use in disposable medical equipment, such as syringes, valves, tubing, and critical implants; artificial heart valves and artificial joints. These materials are versatile, offering durability, biocompatibility, and flexibility, making them suitable in a wide range of medical applications, such as medical tubes, bags, and gloves. The growing healthcare costs in developing economies coupled with technology advancements will further fuel the increasing demand for these critical commodities, rendering them even more indispensable to meet growing healthcare needs across the world. Additionally, the expanding population in emerging economies along with the rising prevalence of chronic diseases is creating a demand for medical elastomers.
“Based on application, implants are the fastest growing application in medical elastomer market during the forecast period, in terms of value.”
Implants are the fastest growing application of medical elastomers due to increasing demand for biocompatible, durable and flexible materials in medical procedures. The rising prevalence of chronic diseases and aging populations are driving the need of durable implants in medical elastomers, as it provides superior orthopedic, dental, and soft tissue implant performance. Flexibility and comfort with least complications further make them appealing. Moreover, the ability of elastomers to be molded into complex shapes and the excellent biocompatibility enhances the future applications of customized implants, thereby further fueling the demand for medical elastomers.
“Based on end-use industry, hospitals & clinics account the largest share in medical elastomer market during the forecast period, in terms of value.”
Hospitals and clinics account for the largest share in the medical elastomer market due to their heavy dependence on medical devices and equipment that utilize elastomer materials. These institutions need a wide range of products based on medical elastomers such as catheters, medical tubing, seals, gaskets, surgical gloves, and implants, in order to ensure appropriate patient care and treatment. However, the growing need for healthcare services due to growing ageing population and rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, and respiratory disorders further boosts the demand for these medical devices. The properties of medical elastomers such as biocompatibility and excellent flexibility & durability along with chemical resistance makes them highly functional for various applications in hospital and clinic applications. These factors, along with the stringent regulatory requirements from healthcare authorities like FDA, ensure that hospitals and clinics are adopting high-quality elastomer-based products. All these factors combined strong healthcare needs, adherence to regulatory requirements, and the drive for advanced, reliable medical devices ensure make hospitals & clinics account largest market share by industry in the medical elastomer market.
“Based on region, Asia Pacific accounts the second largest market for medical elastomer, in terms of value.”
Asia Pacific accounts the second largest market for medical elastomers because of various factors such as economic development, rapid population growth, a good healthcare sector, and increasing demand for medical devices. The rise in investments for healthcare infrastructure in emerging economies like China and India is driving the demand for adoption high-quality medical elastomers into healthcare equipments such as medical tubing, implants, and diagnostic equipment. Large and aging population in the region have added up to this demand as prevalence of chronic diseases is rising among this population. Asia Pacific is, therefore, a growth product concerning medical facility organizations dedicated to better healthcare access, positioning it as a major player in the global medical elastomer market.
In the process of determining and verifying the market size for several segments and subsegments identified through secondary research, extensive primary interviews were conducted. A breakdown of the profiles of the primary interviewees are as follows:
Research Coverage
This report segments the medical elastomer market based on type, technology, application, end-use industry, and region, and provides estimations for the overall value of the market across various regions. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, products and services, key strategies, new product launches, expansions, and mergers and acquisitions associated with the medical elastomer market.
Key benefits of buying this report
This research report focuses on various levels of analysis, including industry analysis (industry trends), market ranking analysis of top players, and company profiles, which together provide an overall view of the competitive landscape, emerging and high-growth segments of the medical elastomer market, high-growth regions, and market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
“Based on application, implants are the fastest growing application in medical elastomer market during the forecast period, in terms of value.”
Implants are the fastest growing application of medical elastomers due to increasing demand for biocompatible, durable and flexible materials in medical procedures. The rising prevalence of chronic diseases and aging populations are driving the need of durable implants in medical elastomers, as it provides superior orthopedic, dental, and soft tissue implant performance. Flexibility and comfort with least complications further make them appealing. Moreover, the ability of elastomers to be molded into complex shapes and the excellent biocompatibility enhances the future applications of customized implants, thereby further fueling the demand for medical elastomers.
“Based on end-use industry, hospitals & clinics account the largest share in medical elastomer market during the forecast period, in terms of value.”
Hospitals and clinics account for the largest share in the medical elastomer market due to their heavy dependence on medical devices and equipment that utilize elastomer materials. These institutions need a wide range of products based on medical elastomers such as catheters, medical tubing, seals, gaskets, surgical gloves, and implants, in order to ensure appropriate patient care and treatment. However, the growing need for healthcare services due to growing ageing population and rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, and respiratory disorders further boosts the demand for these medical devices. The properties of medical elastomers such as biocompatibility and excellent flexibility & durability along with chemical resistance makes them highly functional for various applications in hospital and clinic applications. These factors, along with the stringent regulatory requirements from healthcare authorities like FDA, ensure that hospitals and clinics are adopting high-quality elastomer-based products. All these factors combined strong healthcare needs, adherence to regulatory requirements, and the drive for advanced, reliable medical devices ensure make hospitals & clinics account largest market share by industry in the medical elastomer market.
“Based on region, Asia Pacific accounts the second largest market for medical elastomer, in terms of value.”
Asia Pacific accounts the second largest market for medical elastomers because of various factors such as economic development, rapid population growth, a good healthcare sector, and increasing demand for medical devices. The rise in investments for healthcare infrastructure in emerging economies like China and India is driving the demand for adoption high-quality medical elastomers into healthcare equipments such as medical tubing, implants, and diagnostic equipment. Large and aging population in the region have added up to this demand as prevalence of chronic diseases is rising among this population. Asia Pacific is, therefore, a growth product concerning medical facility organizations dedicated to better healthcare access, positioning it as a major player in the global medical elastomer market.
In the process of determining and verifying the market size for several segments and subsegments identified through secondary research, extensive primary interviews were conducted. A breakdown of the profiles of the primary interviewees are as follows:
- By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
- By Designation: Directors- 35%, Managers - 25%, and Others - 40%
- By Region: North America - 22%, Europe - 22%, Asia Pacific - 45%, RoW – 11%
Research Coverage
This report segments the medical elastomer market based on type, technology, application, end-use industry, and region, and provides estimations for the overall value of the market across various regions. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, products and services, key strategies, new product launches, expansions, and mergers and acquisitions associated with the medical elastomer market.
Key benefits of buying this report
This research report focuses on various levels of analysis, including industry analysis (industry trends), market ranking analysis of top players, and company profiles, which together provide an overall view of the competitive landscape, emerging and high-growth segments of the medical elastomer market, high-growth regions, and market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (Growing demand for medical devices, Technological advancements in healthcare and Prevalence of chronic diseases), restraints (High production costs), opportunities (Growing healthcare investment in emerging economies) and challenges (Stringent regulatory requirements).
- Market Penetration: Comprehensive information on the medical elastomer market offered by top players in the global medical elastomer market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the medical elastomer market.
- Market Development: Comprehensive information about lucrative emerging markets — the report analyzes the markets for medical elastomer market across regions.
- Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the global medical elastomer market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the medical elastomer market
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED AND REGIONAL SCOPE
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 UNITS CONSIDERED
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 List of key secondary sources
2.1.1.2 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 List of key primary interview participants
2.1.2.3 Key industry insights
2.1.2.4 Breakdown of interviews with experts
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.3 GROWTH FORECAST
2.4 DATA TRIANGULATION
2.5 FACTOR ANALYSIS
2.6 RESEARCH ASSUMPTIONS
2.7 RESEARCH LIMITATIONS AND RISK ANALYSIS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL ELASTOMERS MARKET
4.2 MEDICAL ELASTOMERS MARKET, BY TYPE, 2024 VS. 2029 (KILOTON)
4.3 MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024 VS. 2029 (KILOTON)
4.4 MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024 VS. 2029 (KILOTON)
4.5 MEDICAL ELASTOMERS MARKET, BY KEY COUNTRY
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing demand for medical devices
5.2.1.2 Technological advancements in healthcare
5.2.1.3 Prevalence of chronic diseases
5.2.2 RESTRAINTS
5.2.2.1 High production costs
5.2.3 OPPORTUNITIES
5.2.3.1 Growing healthcare investments in emerging economies
5.2.3.2 Increasing use in minimally invasive devices
5.2.4 CHALLENGES
5.2.4.1 Stringent regulatory requirements
5.3 PORTER’S FIVE FORCES ANALYSIS
5.3.1 THREAT FROM NEW ENTRANTS
5.3.2 THREAT OF SUBSTITUTES
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.4 BARGAINING POWER OF BUYERS
5.3.5 INTENSITY OF COMPETITIVE RIVALRY
5.4 KEY STAKEHOLDERS AND BUYING CRITERIA
5.4.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.4.2 BUYING CRITERIA
5.5 MACROECONOMIC OUTLOOK
5.5.1 GDP TRENDS AND FORECASTS
5.6 IMPACT OF AI/GENAI
5.7 VALUE CHAIN ANALYSIS
5.8 ECOSYSTEM ANALYSIS
5.9 CASE STUDY ANALYSIS
5.9.1 KENT ELASTOMERS HELPED IN TRANSITIONING TO NON-LATEX MEDICAL COMPONENTS
5.9.2 COOPER UNIVERSITY HOSPITAL BOOSTS POLYPHENYLENE ETHER RESILIENCE WITH DENTEC SAFETY COMFORT-AIRNXMD
5.9.3 TECNOFLON FKM AS HIGH-PERFORMANCE ALTERNATIVE TO SILICONE IN ORTHOPEDIC APPLICATIONS
5.10 REGULATORY LANDSCAPE
5.10.1 ENVIRONMENTAL REGULATIONS
5.10.2 NORTH AMERICA
5.10.3 ASIA PACIFIC
5.10.4 EUROPE
5.10.5 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11 TECHNOLOGY ANALYSIS
5.11.1 KEY TECHNOLOGIES
5.11.1.1 Extrusion technology
5.11.1.2 Compression molding
5.11.2 COMPLEMENTARY TECHNOLOGIES
5.11.2.1 Co-extrusion technology
5.11.3 ADJACENT TECHNOLOGIES
5.11.3.1 Additive manufacturing technology
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.13 TRADE ANALYSIS
5.13.1 IMPORT SCENARIO (HS CODE 391000)
5.13.2 EXPORT SCENARIO (HS CODE 391000)
5.13.3 IMPORT SCENARIO (HS CODE 400270)
5.13.4 EXPORT SCENARIO (HS CODE 400270)
5.14 KEY CONFERENCES AND EVENTS, 2024–2025
5.15 PRICING ANALYSIS
5.15.1 AVERAGE SELLING PRICE TREND OF MEDICAL ELASTOMERS, BY REGION
5.15.2 AVERAGE SELLING PRICE TREND OF MEDICAL ELASTOMERS,
BY APPLICATION
5.15.3 AVERAGE SELLING PRICE TREND OF MEDICAL ELASTOMERS,
BY END-USE INDUSTRY
5.16 INVESTMENT AND FUNDING SCENARIO
5.17 PATENT ANALYSIS
5.17.1 INTRODUCTION
5.17.2 LEGAL STATUS OF PATENTS
5.17.3 JURISDICTION ANALYSIS
5.18 LIST OF POTENTIAL CUSTOMERS
6 MEDICAL ELASTOMERS MARKET, BY TECHNOLOGY
6.1 INTRODUCTION
6.2 EXTRUSION
6.3 INJECTION MOLDING
6.4 COMPRESSION MOLDING
6.5 OTHER TECHNOLOGIES
7 MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY
7.1 INTRODUCTION
7.2 HOSPITALS & CLINICS
7.2.1 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET
7.3 PHARMACEUTICAL
7.3.1 CRUCIAL ROLE OF ELASTOMERS IN PACKAGING AND DRUG DELIVERY SYSTEMS TO PROPEL ADOPTION
7.4 MEDICAL DEVICE MANUFACTURING
7.4.1 RISING DEMAND FOR ADVANCED MEDICAL DEVICES TO SUPPORT MARKET GROWTH
7.5 OTHER END-USE INDUSTRIES
8 MEDICAL ELASTOMERS MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 MEDICAL TUBING
8.2.1 HIGH CONSUMPTION IN ADVANCING MEDICAL TUBING SOLUTIONS TO DRIVE MARKET
8.3 CATHETERS
8.3.1 VITAL ROLE IN PRODUCTION OF CATHETERS TO PROPEL GROWTH
8.4 GLOVES
8.4.1 INCREASING NEED FOR PERSONAL PROTECTIVE EQUIPMENT TO INCREASE DEMAND
8.5 SYRINGES
8.5.1 PRE-FILLED SYRINGES
8.5.1.1 Reduce risk of dosing errors—key factor driving adoption
8.5.2 NON-PRE-FILLED SYRINGES
8.5.2.1 Increasing incidence of chronic diseases to propel adoption
8.5.3 VIALS
8.5.3.1 Increasing need for safe and effective drug delivery systems to drive market
8.6 MEDICAL & INFUSION BAGS
8.6.1 RISE IN HOSPITAL-ACQUIRED INFECTIONS TO SUPPORT MARKET GROWTH
8.7 IMPLANTS
8.7.1 INCREASING PREVALENCE OF AGE-RELATED HEALTH CONDITIONS TO DRIVE MARKET
8.8 OTHER APPLICATIONS
9 MEDICAL ELASTOMERS MARKET, BY TYPE
9.1 INTRODUCTION
9.2 THERMOSET ELASTOMERS
9.2.1 SILICONE
9.2.1.1 Efficient alternative to latex products in medical and pharmaceutical applications
9.2.1.2 High temperature vulcanized
9.2.1.3 Liquid silicone rubber
9.2.1.4 Room temperature vulcanized
9.2.2 ETHYLENE PROPYLENE DIENE MONOMER
9.2.2.1 Suitable for various medical applications—key factor supporting market growth
9.2.3 OTHER THERMOSET ELASTOMERS
9.3 THERMOPLASTIC ELASTOMERS
9.3.1 THERMOPLASTIC POLYURETHANE
9.3.1.1 Provide efficiency in manufacturing complex designs using extrusion and molding techniques
9.3.2 STYRENE BLOCK COPOLYMERS
9.3.2.1 Biostability of SBC increases utility in medical applications—key factor driving market growth
9.3.3 OTHER THERMOPLASTIC ELASTOMERS
10 MEDICAL ELASTOMERS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.1.1 Rising healthcare spending to drive market
10.2.2 CANADA
10.2.2.1 Expanding healthcare system to support market growth
10.2.3 MEXICO
10.2.3.1 Government initiatives and growth of healthcare sector to drive market
10.3 ASIA PACIFIC
10.3.1 CHINA
10.3.1.1 Growing aging population to drive market
10.3.2 JAPAN
10.3.2.1 Increased focus on infection control and patient safety to propel market
10.3.3 INDIA
10.3.3.1 Increasing investments in healthcare sector to drive market
10.3.4 SOUTH KOREA
10.3.4.1 Rising demand for high quality medical devices to drive market
10.3.5 INDONESIA
10.3.5.1 Rising incidence of chronic diseases to drive market
10.3.6 REST OF ASIA PACIFIC
10.4 EUROPE
10.4.1 GERMANY
10.4.1.1 Increased investments in R&D to drive market
10.4.2 UK
10.4.2.1 Rising geriatric population to support market growth
10.4.3 FRANCE
10.4.3.1 Presence of significant medical device manufacturers to propel market
10.4.4 ITALY
10.4.4.1 Rising demand for medical devices from public hospitals to increase demand
10.4.5 SPAIN
10.4.5.1 Increasing investments in healthcare infrastructure to propel market
10.4.6 REST OF EUROPE
10.5 MIDDLE EAST & AFRICA
10.5.1 GCC COUNTRIES
10.5.1.1 Saudi Arabia
10.5.1.1.1 Need for advanced medical technologies to drive market
10.5.1.2 Rest of GCC countries
10.5.2 SOUTH AFRICA
10.5.2.1 Outbreak of contagious diseases to drive market
10.5.3 REST OF MIDDLE EAST & AFRICA
10.6 SOUTH AMERICA
10.6.1 BRAZIL
10.6.1.1 Largest market for medical elastomers in South America
10.6.2 ARGENTINA
10.6.2.1 Growing demand for medical devices to drive market
10.6.3 REST OF SOUTH AMERICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2019–2024
11.3 REVENUE ANALYSIS, 2021–2023
11.4 MARKET SHARE ANALYSIS, 2023
11.4.1 NORTH AMERICA: MARKET SHARE ANALYSIS, BY APPLICATION, 2023
11.4.2 EUROPE: MARKET SHARE ANALYSIS, BY APPLICATION, 2023
11.4.3 ASIA PACIFIC: MARKET SHARE ANALYSIS, BY APPLICATION, 2023
11.4.4 DOW
11.4.5 EXXON MOBIL CORPORATION
11.4.6 CELANESE CORPORATION
11.4.7 BASF
11.4.8 WACKER CHEMIE AG
11.5 COMPANY VALUATION AND FINANCIAL METRICS
11.6 BRAND/PRODUCT COMPARISON
11.6.1 MEDICAL ELASTOMERS MARKET: BRAND/PRODUCT COMPARISON ANALYSIS
11.6.2 ELASTOLLAN
11.6.3 ENGAGE 8480K HEALTH+
11.6.4 HYTREL
11.6.5 ECDEL
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.7.1 STARS
11.7.2 EMERGING LEADERS
11.7.3 PERVASIVE PLAYERS
11.7.4 PARTICIPANTS
11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.7.5.1 Overall company footprint
11.7.5.2 Region footprint
11.7.5.3 Technology footprint
11.7.5.4 Type Footprint
11.7.5.5 Application footprint
11.7.5.6 Industry footprint
11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.8.1 PROGRESSIVE COMPANIES
11.8.2 RESPONSIVE COMPANIES
11.8.3 DYNAMIC COMPANIES
11.8.4 STARTING BLOCKS
11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
11.8.5.1 Detailed list of startups/SMEs
11.8.5.2 Competitive benchmarking of startups/SMEs
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES
11.9.2 DEALS
11.9.3 EXPANSIONS
11.9.4 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 DOW
12.1.1.1 Business overview
12.1.1.2 Products offered
12.1.1.3 Recent developments
12.1.1.3.1 Other developments
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses and competitive threats
12.1.2 EXXON MOBIL CORPORATION
12.1.2.1 Business overview
12.1.2.2 Products offered
12.1.2.3 MnM view
12.1.2.3.1 Key strengths
12.1.2.3.2 Strategic choices
12.1.2.3.3 Weaknesses and competitive threats
12.1.3 CELANESE CORPORATION
12.1.3.1 Business overview
12.1.3.2 Products offered
12.1.3.3 Recent developments
12.1.3.3.1 Deals
12.1.3.4 MnM view
12.1.3.4.1 Key strengths
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses and competitive threats
12.1.4 BASF
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.4.3 Recent developments
12.1.4.3.1 Expansions
12.1.4.4 MnM view
12.1.4.4.1 Key strengths
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses and competitive threats
12.1.5 WACKER CHEMIE AG
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.5.3 Recent developments
12.1.5.3.1 Product launches
12.1.5.3.2 Expansions
12.1.5.4 MnM view
12.1.5.4.1 Key strengths
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses and competitive threats
12.1.6 EASTMAN CHEMICAL COMPANY
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.6.3 MnM view
12.1.6.3.1 Key strengths
12.1.6.3.2 Strategic choices
12.1.6.3.3 Weaknesses and competitive threats
12.1.7 SYENSQO
12.1.7.1 Business overview
12.1.7.2 Products offered
12.1.7.3 Recent developments
12.1.7.3.1 Other developments
12.1.7.4 MnM view
12.1.7.4.1 Key strengths
12.1.7.4.2 Strategic choices
12.1.7.4.3 Weaknesses and competitive threats
12.1.8 KURARAY CO., LTD
12.1.8.1 Business overview
12.1.8.2 Products offered
12.1.8.3 MnM view
12.1.8.3.1 Key strengths
12.1.8.3.2 Strategic choices
12.1.8.3.3 Weaknesses and competitive threats
12.1.9 MITSUBISHI CHEMICAL GROUP CORPORATION
12.1.9.1 Business overview
12.1.9.2 Products offered
12.1.9.3 Recent developments
12.1.9.3.1 Other developments
12.1.9.3.2 Deals
12.1.9.4 MnM view
12.1.10 MOMENTIVE PERFORMANCE MATERIALS
12.1.10.1 Business overview
12.1.10.2 Products offered
12.1.10.3 MnM view
12.1.11 ENVALIOR
12.1.11.1 Business overview
12.1.11.2 Products offered
12.1.12 ZEON CORPORATION
12.1.12.1 Business overview
12.1.12.2 Products offered
12.1.13 THE LUBRIZOL CORPORATION
12.1.13.1 Business overview
12.1.13.2 Products offered
12.1.13.3 MnM view
12.2 OTHER PLAYERS
12.2.1 KRATON CORPORATION
12.2.2 FOSTER CORPORATION
12.2.3 BIOMERICS
12.2.4 RTP COMPANY
12.2.5 ROMAR ENGINEERING
12.2.6 THE RUBBER GROUP
12.2.7 KENT ELASTOMER PRODUCTS
12.2.8 RAUMEDIC AG
12.2.9 THE HYGENIC COMPANY, LLC
12.2.10 HEXAPOL AB
12.2.11 TEKNI-PLEX, INC
12.2.12 TRINSEO
12.2.13 TRELLEBORG AB
12.2.14 SAINT-GOBAIN
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED AND REGIONAL SCOPE
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 UNITS CONSIDERED
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 List of key secondary sources
2.1.1.2 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 List of key primary interview participants
2.1.2.3 Key industry insights
2.1.2.4 Breakdown of interviews with experts
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.3 GROWTH FORECAST
2.4 DATA TRIANGULATION
2.5 FACTOR ANALYSIS
2.6 RESEARCH ASSUMPTIONS
2.7 RESEARCH LIMITATIONS AND RISK ANALYSIS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL ELASTOMERS MARKET
4.2 MEDICAL ELASTOMERS MARKET, BY TYPE, 2024 VS. 2029 (KILOTON)
4.3 MEDICAL ELASTOMERS MARKET, BY APPLICATION, 2024 VS. 2029 (KILOTON)
4.4 MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY, 2024 VS. 2029 (KILOTON)
4.5 MEDICAL ELASTOMERS MARKET, BY KEY COUNTRY
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing demand for medical devices
5.2.1.2 Technological advancements in healthcare
5.2.1.3 Prevalence of chronic diseases
5.2.2 RESTRAINTS
5.2.2.1 High production costs
5.2.3 OPPORTUNITIES
5.2.3.1 Growing healthcare investments in emerging economies
5.2.3.2 Increasing use in minimally invasive devices
5.2.4 CHALLENGES
5.2.4.1 Stringent regulatory requirements
5.3 PORTER’S FIVE FORCES ANALYSIS
5.3.1 THREAT FROM NEW ENTRANTS
5.3.2 THREAT OF SUBSTITUTES
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.4 BARGAINING POWER OF BUYERS
5.3.5 INTENSITY OF COMPETITIVE RIVALRY
5.4 KEY STAKEHOLDERS AND BUYING CRITERIA
5.4.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.4.2 BUYING CRITERIA
5.5 MACROECONOMIC OUTLOOK
5.5.1 GDP TRENDS AND FORECASTS
5.6 IMPACT OF AI/GENAI
5.7 VALUE CHAIN ANALYSIS
5.8 ECOSYSTEM ANALYSIS
5.9 CASE STUDY ANALYSIS
5.9.1 KENT ELASTOMERS HELPED IN TRANSITIONING TO NON-LATEX MEDICAL COMPONENTS
5.9.2 COOPER UNIVERSITY HOSPITAL BOOSTS POLYPHENYLENE ETHER RESILIENCE WITH DENTEC SAFETY COMFORT-AIRNXMD
5.9.3 TECNOFLON FKM AS HIGH-PERFORMANCE ALTERNATIVE TO SILICONE IN ORTHOPEDIC APPLICATIONS
5.10 REGULATORY LANDSCAPE
5.10.1 ENVIRONMENTAL REGULATIONS
5.10.2 NORTH AMERICA
5.10.3 ASIA PACIFIC
5.10.4 EUROPE
5.10.5 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11 TECHNOLOGY ANALYSIS
5.11.1 KEY TECHNOLOGIES
5.11.1.1 Extrusion technology
5.11.1.2 Compression molding
5.11.2 COMPLEMENTARY TECHNOLOGIES
5.11.2.1 Co-extrusion technology
5.11.3 ADJACENT TECHNOLOGIES
5.11.3.1 Additive manufacturing technology
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.13 TRADE ANALYSIS
5.13.1 IMPORT SCENARIO (HS CODE 391000)
5.13.2 EXPORT SCENARIO (HS CODE 391000)
5.13.3 IMPORT SCENARIO (HS CODE 400270)
5.13.4 EXPORT SCENARIO (HS CODE 400270)
5.14 KEY CONFERENCES AND EVENTS, 2024–2025
5.15 PRICING ANALYSIS
5.15.1 AVERAGE SELLING PRICE TREND OF MEDICAL ELASTOMERS, BY REGION
5.15.2 AVERAGE SELLING PRICE TREND OF MEDICAL ELASTOMERS,
BY APPLICATION
5.15.3 AVERAGE SELLING PRICE TREND OF MEDICAL ELASTOMERS,
BY END-USE INDUSTRY
5.16 INVESTMENT AND FUNDING SCENARIO
5.17 PATENT ANALYSIS
5.17.1 INTRODUCTION
5.17.2 LEGAL STATUS OF PATENTS
5.17.3 JURISDICTION ANALYSIS
5.18 LIST OF POTENTIAL CUSTOMERS
6 MEDICAL ELASTOMERS MARKET, BY TECHNOLOGY
6.1 INTRODUCTION
6.2 EXTRUSION
6.3 INJECTION MOLDING
6.4 COMPRESSION MOLDING
6.5 OTHER TECHNOLOGIES
7 MEDICAL ELASTOMERS MARKET, BY END-USE INDUSTRY
7.1 INTRODUCTION
7.2 HOSPITALS & CLINICS
7.2.1 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET
7.3 PHARMACEUTICAL
7.3.1 CRUCIAL ROLE OF ELASTOMERS IN PACKAGING AND DRUG DELIVERY SYSTEMS TO PROPEL ADOPTION
7.4 MEDICAL DEVICE MANUFACTURING
7.4.1 RISING DEMAND FOR ADVANCED MEDICAL DEVICES TO SUPPORT MARKET GROWTH
7.5 OTHER END-USE INDUSTRIES
8 MEDICAL ELASTOMERS MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 MEDICAL TUBING
8.2.1 HIGH CONSUMPTION IN ADVANCING MEDICAL TUBING SOLUTIONS TO DRIVE MARKET
8.3 CATHETERS
8.3.1 VITAL ROLE IN PRODUCTION OF CATHETERS TO PROPEL GROWTH
8.4 GLOVES
8.4.1 INCREASING NEED FOR PERSONAL PROTECTIVE EQUIPMENT TO INCREASE DEMAND
8.5 SYRINGES
8.5.1 PRE-FILLED SYRINGES
8.5.1.1 Reduce risk of dosing errors—key factor driving adoption
8.5.2 NON-PRE-FILLED SYRINGES
8.5.2.1 Increasing incidence of chronic diseases to propel adoption
8.5.3 VIALS
8.5.3.1 Increasing need for safe and effective drug delivery systems to drive market
8.6 MEDICAL & INFUSION BAGS
8.6.1 RISE IN HOSPITAL-ACQUIRED INFECTIONS TO SUPPORT MARKET GROWTH
8.7 IMPLANTS
8.7.1 INCREASING PREVALENCE OF AGE-RELATED HEALTH CONDITIONS TO DRIVE MARKET
8.8 OTHER APPLICATIONS
9 MEDICAL ELASTOMERS MARKET, BY TYPE
9.1 INTRODUCTION
9.2 THERMOSET ELASTOMERS
9.2.1 SILICONE
9.2.1.1 Efficient alternative to latex products in medical and pharmaceutical applications
9.2.1.2 High temperature vulcanized
9.2.1.3 Liquid silicone rubber
9.2.1.4 Room temperature vulcanized
9.2.2 ETHYLENE PROPYLENE DIENE MONOMER
9.2.2.1 Suitable for various medical applications—key factor supporting market growth
9.2.3 OTHER THERMOSET ELASTOMERS
9.3 THERMOPLASTIC ELASTOMERS
9.3.1 THERMOPLASTIC POLYURETHANE
9.3.1.1 Provide efficiency in manufacturing complex designs using extrusion and molding techniques
9.3.2 STYRENE BLOCK COPOLYMERS
9.3.2.1 Biostability of SBC increases utility in medical applications—key factor driving market growth
9.3.3 OTHER THERMOPLASTIC ELASTOMERS
10 MEDICAL ELASTOMERS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 US
10.2.1.1 Rising healthcare spending to drive market
10.2.2 CANADA
10.2.2.1 Expanding healthcare system to support market growth
10.2.3 MEXICO
10.2.3.1 Government initiatives and growth of healthcare sector to drive market
10.3 ASIA PACIFIC
10.3.1 CHINA
10.3.1.1 Growing aging population to drive market
10.3.2 JAPAN
10.3.2.1 Increased focus on infection control and patient safety to propel market
10.3.3 INDIA
10.3.3.1 Increasing investments in healthcare sector to drive market
10.3.4 SOUTH KOREA
10.3.4.1 Rising demand for high quality medical devices to drive market
10.3.5 INDONESIA
10.3.5.1 Rising incidence of chronic diseases to drive market
10.3.6 REST OF ASIA PACIFIC
10.4 EUROPE
10.4.1 GERMANY
10.4.1.1 Increased investments in R&D to drive market
10.4.2 UK
10.4.2.1 Rising geriatric population to support market growth
10.4.3 FRANCE
10.4.3.1 Presence of significant medical device manufacturers to propel market
10.4.4 ITALY
10.4.4.1 Rising demand for medical devices from public hospitals to increase demand
10.4.5 SPAIN
10.4.5.1 Increasing investments in healthcare infrastructure to propel market
10.4.6 REST OF EUROPE
10.5 MIDDLE EAST & AFRICA
10.5.1 GCC COUNTRIES
10.5.1.1 Saudi Arabia
10.5.1.1.1 Need for advanced medical technologies to drive market
10.5.1.2 Rest of GCC countries
10.5.2 SOUTH AFRICA
10.5.2.1 Outbreak of contagious diseases to drive market
10.5.3 REST OF MIDDLE EAST & AFRICA
10.6 SOUTH AMERICA
10.6.1 BRAZIL
10.6.1.1 Largest market for medical elastomers in South America
10.6.2 ARGENTINA
10.6.2.1 Growing demand for medical devices to drive market
10.6.3 REST OF SOUTH AMERICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2019–2024
11.3 REVENUE ANALYSIS, 2021–2023
11.4 MARKET SHARE ANALYSIS, 2023
11.4.1 NORTH AMERICA: MARKET SHARE ANALYSIS, BY APPLICATION, 2023
11.4.2 EUROPE: MARKET SHARE ANALYSIS, BY APPLICATION, 2023
11.4.3 ASIA PACIFIC: MARKET SHARE ANALYSIS, BY APPLICATION, 2023
11.4.4 DOW
11.4.5 EXXON MOBIL CORPORATION
11.4.6 CELANESE CORPORATION
11.4.7 BASF
11.4.8 WACKER CHEMIE AG
11.5 COMPANY VALUATION AND FINANCIAL METRICS
11.6 BRAND/PRODUCT COMPARISON
11.6.1 MEDICAL ELASTOMERS MARKET: BRAND/PRODUCT COMPARISON ANALYSIS
11.6.2 ELASTOLLAN
11.6.3 ENGAGE 8480K HEALTH+
11.6.4 HYTREL
11.6.5 ECDEL
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.7.1 STARS
11.7.2 EMERGING LEADERS
11.7.3 PERVASIVE PLAYERS
11.7.4 PARTICIPANTS
11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.7.5.1 Overall company footprint
11.7.5.2 Region footprint
11.7.5.3 Technology footprint
11.7.5.4 Type Footprint
11.7.5.5 Application footprint
11.7.5.6 Industry footprint
11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.8.1 PROGRESSIVE COMPANIES
11.8.2 RESPONSIVE COMPANIES
11.8.3 DYNAMIC COMPANIES
11.8.4 STARTING BLOCKS
11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
11.8.5.1 Detailed list of startups/SMEs
11.8.5.2 Competitive benchmarking of startups/SMEs
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES
11.9.2 DEALS
11.9.3 EXPANSIONS
11.9.4 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 DOW
12.1.1.1 Business overview
12.1.1.2 Products offered
12.1.1.3 Recent developments
12.1.1.3.1 Other developments
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses and competitive threats
12.1.2 EXXON MOBIL CORPORATION
12.1.2.1 Business overview
12.1.2.2 Products offered
12.1.2.3 MnM view
12.1.2.3.1 Key strengths
12.1.2.3.2 Strategic choices
12.1.2.3.3 Weaknesses and competitive threats
12.1.3 CELANESE CORPORATION
12.1.3.1 Business overview
12.1.3.2 Products offered
12.1.3.3 Recent developments
12.1.3.3.1 Deals
12.1.3.4 MnM view
12.1.3.4.1 Key strengths
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses and competitive threats
12.1.4 BASF
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.4.3 Recent developments
12.1.4.3.1 Expansions
12.1.4.4 MnM view
12.1.4.4.1 Key strengths
12.1.4.4.2 Strategic choices
12.1.4.4.3 Weaknesses and competitive threats
12.1.5 WACKER CHEMIE AG
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.5.3 Recent developments
12.1.5.3.1 Product launches
12.1.5.3.2 Expansions
12.1.5.4 MnM view
12.1.5.4.1 Key strengths
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses and competitive threats
12.1.6 EASTMAN CHEMICAL COMPANY
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.6.3 MnM view
12.1.6.3.1 Key strengths
12.1.6.3.2 Strategic choices
12.1.6.3.3 Weaknesses and competitive threats
12.1.7 SYENSQO
12.1.7.1 Business overview
12.1.7.2 Products offered
12.1.7.3 Recent developments
12.1.7.3.1 Other developments
12.1.7.4 MnM view
12.1.7.4.1 Key strengths
12.1.7.4.2 Strategic choices
12.1.7.4.3 Weaknesses and competitive threats
12.1.8 KURARAY CO., LTD
12.1.8.1 Business overview
12.1.8.2 Products offered
12.1.8.3 MnM view
12.1.8.3.1 Key strengths
12.1.8.3.2 Strategic choices
12.1.8.3.3 Weaknesses and competitive threats
12.1.9 MITSUBISHI CHEMICAL GROUP CORPORATION
12.1.9.1 Business overview
12.1.9.2 Products offered
12.1.9.3 Recent developments
12.1.9.3.1 Other developments
12.1.9.3.2 Deals
12.1.9.4 MnM view
12.1.10 MOMENTIVE PERFORMANCE MATERIALS
12.1.10.1 Business overview
12.1.10.2 Products offered
12.1.10.3 MnM view
12.1.11 ENVALIOR
12.1.11.1 Business overview
12.1.11.2 Products offered
12.1.12 ZEON CORPORATION
12.1.12.1 Business overview
12.1.12.2 Products offered
12.1.13 THE LUBRIZOL CORPORATION
12.1.13.1 Business overview
12.1.13.2 Products offered
12.1.13.3 MnM view
12.2 OTHER PLAYERS
12.2.1 KRATON CORPORATION
12.2.2 FOSTER CORPORATION
12.2.3 BIOMERICS
12.2.4 RTP COMPANY
12.2.5 ROMAR ENGINEERING
12.2.6 THE RUBBER GROUP
12.2.7 KENT ELASTOMER PRODUCTS
12.2.8 RAUMEDIC AG
12.2.9 THE HYGENIC COMPANY, LLC
12.2.10 HEXAPOL AB
12.2.11 TEKNI-PLEX, INC
12.2.12 TRINSEO
12.2.13 TRELLEBORG AB
12.2.14 SAINT-GOBAIN
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
